Your session is about to expire
← Back to Search
EDTA Eye Drops vs. Abreva for Cold Sores
Study Summary
This trial will test a new drug to see if it is effective in treating cold sores. The study will last 10 days, and patients will be asked to rate their pain levels and document any unusual symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 1708 Patients • NCT00044213Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 65 years old.I have had cold sores from sun exposure for at least a year.You have a history of using alcohol or drugs excessively.I haven't used a tanning bed, had a sunburn, or been on a beach vacation in the last 2 weeks.I haven't taken steroids, immune suppressants, or chemotherapy in the last 30 days.I have skin issues where my cold sores usually appear.I feel warning signs before a cold sore outbreak.I am currently immunosuppressed due to a condition like HIV or treatments like chemotherapy.I have been on antiviral medication in the last 30 days.I have been treated with EED before.I can remember where my last or most common illness outbreak occurred.Half of my cold sore outbreaks happen after sun exposure.You have fair or light skin.I have had at least one cold sore outbreak in the last year.I do not have a cold, flu, or any illness that could worsen my health or affect study results.You have received a herpes simplex vaccine in the past.I have a history of sensitivity to sunlight or lupus, or I'm currently using medication that increases my sensitivity to sunlight.I cannot stop taking painkillers or anti-inflammatory drugs for the study.I need stronger medication than acetaminophen for my HSV outbreaks.
- Group 1: Study Drug (EDTA Eye Drops)
- Group 2: Active Comparator (Abreva)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are actively engaging in this experiment?
"This clinical trial has ended its recruitment process, having first been advertised on January 20th 2022 and last edited on November 19th 2022. However, there are plenty of other available studies - 28 trials for oral herpes simplex and 1 study involving EDTA are currently enrolling participants."
Is this scientific experiment welcoming new participants?
"Unfortunately, the specified clinical trial is no longer open to applicants. It was originally posted on January 20th 2022 and had its last update on November 19th 2022. However, there are presently 28 trials for oral herpes simplex that remain available as well as one concerning EDTA which welcomes participants."
Does this experiment have a maximum age limit for participants?
"The age criterion for this medical experiment requires participants to be between 18 and 65. For those under the legal age limit, there are six trials available; over-65s have access to 24 different studies."
What adverse effects have been associated with EDTA exposure?
"Despite being a Phase 2 trial with limited data on efficacy, EDTA has been deemed somewhat safe by our team at Power and thus given a score of 2."
Have any other experiments used EDTA in the past?
"Presently, there is one active clinical trial assessing EDTA's efficacy. This advanced research is not in phase 3 yet and has its primary study site located in Murray, Utah with an additional branch based elsewhere."
Could I gain admittance to this research project?
"Eligibility criteria for this trial necessitate that patients have oral herpes simplex and are aged between 18 to 65. Approximately 20 people need to be recruited in total."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger